Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients

Journal of Medical Microbiology

Volumn 50, Issue 6, 2001, Pages 535-546

  Sajjan, Umadevi ^d   Corey, Mary ^a   Humar, Atul ^b   Tullis, Elizabeth ^c   Cutz, Ernest ^a   Ackerley, Cameron ^a   Forstner, Janet ^d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BURKHOLDERIA CEPACIA; CLINICAL ARTICLE; CYSTIC FIBROSIS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; LUNG; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

EID: 0035020777     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-50-6-535     Document Type: Article

References (36)

1. 1. Baltimore RS, Christie CDC, Smith GJW. Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 1989; 140: 1650-1661.
2. 2. Potts SB, Roggli VL, Spock A. Immunohistologic quantification of Pseudomonas aeruginosa in the tracheobronchial tree from patients with cystic fibrosis. Pediatr Pathol Lab Med 1995; 15: 707-721.
3. 3. Ulrich M, Herbert S, Berger J et al. Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence. Am J Respir Cell Mol Biol 1998; 19: 83-91.
4. 4. Möller LVM, Timens W, van der Bij W et al. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am J Respir Crit Care Med 1998; 157: 950-956.
5. 5. LiPuma JJ. Burkholderia cepacia. Management issues and new insights. Clin Chest Med 1998; 19: 473-486.
6. 6. Sun L, Jiang R-Z, Steinbach S et al. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Med 1995; 1: 661-666.
7. 7. Vandamme P, Holmes B, Vancanneyt M et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 1997; 47: 1188-1200.
8. 8. Sajjan US, Sun L, Goldstein R, Forstner JF. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol 1995; 177; 1030-1038.
9. 9. Sajjan US, Corey M, Karmali MA. Forstner JF. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest 1992; 89: 648-656.
10. 10. Hutchison ML, Poxton IR, Govan JR. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation by mammalian phagocytes. Infect Immun 1998; 66; 2033-2039.
11. 11. Darling P, Chan M, Cox AD, Sokol PA. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun 1998; 66: 874-877.
12. 12. Hughes JE, Stewart J, Barclay GR, Govan JRW. Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun 1997; 65: 4281-4287.
13. 13. Zughaier SM, Ryley HC, Jackson SK. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect Immun 1999; 67: 1505-1507.
14. 14. McKevitt AI, Bajaksouzian S, Klinger JD, Woods DE. Purification and characterization of an extracellular protease from Pseudomonas cepacia. Infect Immun 1989; 57: 771-778.
15. 15. Lonon MK, Woods DE, Straus DC. Production of lipase by clinical isolates of Pseudomonas cepacia. J Clin Microbiol 1988; 26: 979-984.
16. 16. Zughaier SM, Ryley HC, Jackson SK. A melanin pigment purified from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion. Infect Immun 1999; 67: 908-913.
17. 17. Sajjan US, Forstner JF. Identification of the mucin-binding adhesin of isolated Pseudomonas cepacia from patients with cystic fibrosis. Infect Immun 1992; 60; 1434-1440.
18. 18. Sajjan US, Forstner JF, Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells. Infect Immun 1993; 61: 3157-3163.
19. 19. Sajjan US, Sylvester FA, Forstner JF. Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun 2000; 68: 1787-1795.
20. 20. Sajjan US, Wu Y, Kent G, Forstner J. Preferential adherence of cable-piliated Burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol 2000; 49: 875-885.
21. 21. Saini LS, Galsworthy SB, John MA, Valvano MA. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 1999; 145: 3465-3475.
22. 22. Martin DW, Mohr CD. Invasion and intracellular survival of Burkholderia cepacia. Infect Immun 2000; 68: 24-29.
23. 23. Burns JL, Jonas M, Chi EY, Clark DK, Berger A, Griffith A. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun 1996; 64: 4054-4059.
24. 24. Baird RM, Brown H, Smith AW, Watson ML. Burkholderia cepacia is resistant to the antimicrobial activity of airway epithelial cells. Immunopharmacology 1999; 44: 267-272.
25. 25. Sylvester FA, Sajjan US, Forstner IF. Burkholderia (basonym Pseudomonas) cepacia binding to lipid receptors. Infect Immun 1996; 64: 1420-1425.
26. 26. Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-748.
27. 27. Tomashefski JF, Thomassen M-J, Bruce MC, Goldberg HI, Konstan MW, Stern RC. Pseudomonas cepacia-associated pneumonia in cystic fibrosis. Arch Pathol Lab Med 1988; 112; 166-172.
28. 28. Johansen HK, Kovesi TA, Koch C, Corey M, Hoiby N, Levison H, Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen. Pediatr Pulmonol 1998; 26: 89-96.
29. 29. Isles A, Maclusky I, Corey M et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104: 206-210.
30. 30. Frangolias DD, Mahenthiralingam E, Rae S et al. Burkholderia cepacia in cystic fibrosis: variable disease course. Am J Respir Crit Care Med 1999; 160: 1572-1577.
31. 31. Tablan OC, Chorba TL, Schidlow DV et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985; 107: 382-387.
32. 32. Chaparro C, Gutierrez CA, Chan C, Tullis E, Hutcheon M, Keshavjee S. Lung transplantation for cystic fibrosis: the Toronto experience. In: Thirteenth Annual North American Cystic Fibrosis Conference. Seattle, Washington. Pediatr Pulmonol 1999; Suppl 19: Abstract 450.
33. 33. Snell GI, de Hoyos A, Krajden M, Winton T, Mauere JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest 1993; 103: 466-471.
34. 34. Ledson MJ, Gallagher MJ, Corkill JE, Hart CA, Walshaw MJ. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 1998; 53: 432-436.
35. 35. Kaplan SL, Mason EO, Wiedermann BL. Role of adherence in the pathogenesis of Haemophilus inftuenzae type b infection in infant rats. Infect Immun 1983; 42: 612-617.
36. 36. Alkan ML, Wong L, Silverblatt FJ. Change in degree of type 1 piliation of Escherichia coli during experimental peritonitis in the mouse. Infect Immun 1986; 54: 549-554.